Carsten Linnemann, Ph.D., CEO of Neogene Therapeutics and Head of Oncology Cell Therapy Clinical Development, AstraZeneca joins Cell & Gene: The Podcast’s Erin Harris to discuss T-cell receptor (TCR) ...
As professionals within the life sciences industry, a new era is upon us, marked by the pursuit of efficiency. In part this has been driven by legislative measures such as the Inflation Reduction Act ...
Cell therapies hold promise for treating malignancies that are currently untreatable. Methods like chimeric antigen receptor (CAR) T cell therapies are being tested in a number of clinical trials, ...
Examine the pivotal role of comprehensive data analysis solutions in enhancing competitive intelligence within the pharmaceutical industry. As the industry landscape shifts with the rise of generic ...
Stop spending thousands of man-hours on SDTM, ADaM and TFL generation and accelerate the delivery of clinical discoveries to patients. Transform your biostatistics deliveries with ThoughtSphere.
In the rapidly evolving landscape of pharmaceutical development, AI promises to revolutionize the entire drug discovery and development process, impacting target discovery, clinical trial design, site ...